Cover
Cover - shares | 9 Months Ended | |
Dec. 31, 2021 | Jan. 31, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-39010 | |
Entity Registrant Name | Dynatrace, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 47-2386428 | |
Entity Address, Address Line One | 1601 Trapelo Road, Suite 116 | |
Entity Address, Postal Zip Code | 02451 | |
Entity Address, City or Town | Waltham | |
Entity Address, State or Province | MA | |
City Area Code | 617 | |
Local Phone Number | 530-1000 | |
Title of 12(b) Security | Common stock, par value $0.001 per share | |
Trading Symbol | DT | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 285,744,612 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Entity Central Index Key | 0001773383 | |
Current Fiscal Year End Date | --03-31 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2021 | Mar. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 408,723 | $ 324,962 |
Accounts receivable, net | 264,293 | 242,079 |
Deferred commissions, current | 57,978 | 48,986 |
Prepaid expenses and other current assets | 81,326 | 64,255 |
Total current assets | 812,320 | 680,282 |
Property and equipment, net | 41,984 | 36,916 |
Operating lease right-of-use assets, net | 59,306 | 42,959 |
Goodwill | 1,281,764 | 1,271,195 |
Other intangible assets, net | 117,908 | 149,484 |
Deferred tax assets, net | 16,390 | 16,811 |
Deferred commissions, non-current | 58,086 | 48,638 |
Other assets | 10,003 | 9,933 |
Total assets | 2,397,761 | 2,256,218 |
Current liabilities: | ||
Accounts payable | 22,256 | 9,621 |
Accrued expenses, current | 116,154 | 119,527 |
Deferred revenue, current | 563,045 | 509,272 |
Operating lease liabilities, current | 11,700 | 9,491 |
Total current liabilities | 713,155 | 647,911 |
Deferred revenue, non-current | 30,937 | 47,504 |
Accrued expenses, non-current | 20,046 | 16,072 |
Operating lease liabilities, non-current | 52,976 | 38,203 |
Deferred tax liabilities | 1,217 | 1,014 |
Long-term debt | 303,415 | 391,913 |
Total liabilities | 1,121,746 | 1,142,617 |
Commitments and contingencies (Note 8) | ||
Shareholders' equity: | ||
Common shares, $0.001 par value, 600,000,000 shares authorized, 285,701,744 and 283,130,238 shares issued and outstanding at December 31, 2021 and March 31, 2021, respectively | 286 | 283 |
Additional paid-in capital | 1,762,789 | 1,653,328 |
Accumulated deficit | (462,277) | (513,799) |
Accumulated other comprehensive loss | (24,783) | (26,211) |
Total shareholders' equity | 1,276,015 | 1,113,601 |
Total liabilities and shareholders' equity | $ 2,397,761 | $ 2,256,218 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2021 | Mar. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common shares, authorized (in shares) | 600,000,000 | 600,000,000 |
Common shares, issued (in shares) | 285,701,744 | 283,130,238 |
Common shares, outstanding (in shares) | 285,701,744 | 283,130,238 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue: | ||||
Total revenue | $ 240,766 | $ 182,911 | $ 676,860 | $ 507,005 |
Cost of revenue: | ||||
Amortization of acquired technology | 3,944 | 3,831 | 11,638 | 11,487 |
Total cost of revenue | 44,460 | 33,120 | 124,960 | 92,373 |
Gross profit | 196,306 | 149,791 | 551,900 | 414,632 |
Operating expenses: | ||||
Research and development | 40,876 | 28,730 | 113,509 | 79,747 |
Sales and marketing | 94,033 | 64,829 | 260,816 | 170,682 |
General and administrative | 32,643 | 23,442 | 91,254 | 67,079 |
Amortization of other intangibles | 7,539 | 8,685 | 22,618 | 26,057 |
Restructuring and other | 0 | (2) | 25 | 23 |
Total operating expenses | 175,091 | 125,684 | 488,222 | 343,588 |
Income from operations | 21,215 | 24,107 | 63,678 | 71,044 |
Interest expense, net | (2,450) | (3,455) | (7,958) | (11,170) |
Other (expense) income, net | (1,357) | 2,526 | (1,345) | 2,744 |
Income before income taxes | 17,408 | 23,178 | 54,375 | 62,618 |
Income tax expense | (2,821) | (4,762) | (2,853) | (13,858) |
Net income | $ 14,587 | $ 18,416 | $ 51,522 | $ 48,760 |
Net income per share: | ||||
Basic (in dollars per share) | $ 0.05 | $ 0.07 | $ 0.18 | $ 0.17 |
Diluted (in dollars per share) | $ 0.05 | $ 0.06 | $ 0.18 | $ 0.17 |
Weighted average shares outstanding: | ||||
Basic (in shares) | 284,722 | 281,010 | 283,773 | 280,057 |
Diluted (in shares) | 291,845 | 286,427 | 290,895 | 285,884 |
Subscription | ||||
Revenue: | ||||
Total revenue | $ 226,290 | $ 170,308 | $ 635,411 | $ 472,338 |
Cost of revenue: | ||||
Cost of revenues | 28,284 | 20,382 | 80,401 | 55,415 |
License | ||||
Revenue: | ||||
Total revenue | 2 | 257 | 52 | 1,337 |
Service | ||||
Revenue: | ||||
Total revenue | 14,474 | 12,346 | 41,397 | 33,330 |
Cost of revenue: | ||||
Cost of revenues | $ 12,232 | $ 8,907 | $ 32,921 | $ 25,471 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 14,587 | $ 18,416 | $ 51,522 | $ 48,760 |
Other comprehensive income (loss) | ||||
Foreign currency translation adjustment | 692 | (4,786) | 1,428 | (9,920) |
Total other comprehensive income (loss) | 692 | (4,786) | 1,428 | (9,920) |
Comprehensive income | $ 15,279 | $ 13,630 | $ 52,950 | $ 38,840 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Shares | Additional Paid-In Capital | Accumulated Deficit | Accumulated DeficitCumulative Effect, Period of Adoption, Adjustment | Accumulated Other Comprehensive Loss |
Beginning balance (in shares) at Mar. 31, 2020 | 280,853,000 | ||||||
Beginning balance at Mar. 31, 2020 | $ 965,704 | $ 306 | $ 281 | $ 1,573,347 | $ (589,819) | $ 306 | $ (18,105) |
Increase (Decrease) in Partners' Capital [Roll Forward] | |||||||
Foreign currency translation | (9,920) | (9,920) | |||||
Restricted stock units vested (in shares) | 1,035,000 | ||||||
Restricted stock awards forfeited (in shares) | (103,000) | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 331,000 | ||||||
Issuance of common stock related to employee stock purchase plan | 9,195 | 9,195 | |||||
Exercise of stock options (in shares) | 427,000 | ||||||
Exercise of stock options | 6,849 | 6,849 | |||||
Share-based compensation | 43,091 | 43,091 | |||||
Equity repurchases | $ (36) | (36) | |||||
Accounting Standards Update [Extensible List] | Accounting Standards Update 2016-02 [Member] | ||||||
Net income | $ 48,760 | 48,760 | |||||
Ending balance (in shares) at Dec. 31, 2020 | 282,543,000 | ||||||
Ending balance at Dec. 31, 2020 | 1,063,949 | $ 281 | 1,632,446 | (540,753) | (28,025) | ||
Beginning balance (in shares) at Sep. 30, 2020 | 282,024,000 | ||||||
Beginning balance at Sep. 30, 2020 | 1,027,119 | $ 281 | 1,609,246 | (559,169) | (23,239) | ||
Increase (Decrease) in Partners' Capital [Roll Forward] | |||||||
Foreign currency translation | (4,786) | (4,786) | |||||
Restricted stock units vested (in shares) | 229,000 | ||||||
Restricted stock awards forfeited (in shares) | (7,000) | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 172,000 | ||||||
Issuance of common stock related to employee stock purchase plan | 5,603 | 5,603 | |||||
Exercise of stock options (in shares) | 125,000 | ||||||
Exercise of stock options | 2,020 | 2,020 | |||||
Share-based compensation | 15,588 | 15,588 | |||||
Equity repurchases | (11) | (11) | |||||
Net income | 18,416 | 18,416 | |||||
Ending balance (in shares) at Dec. 31, 2020 | 282,543,000 | ||||||
Ending balance at Dec. 31, 2020 | $ 1,063,949 | $ 281 | 1,632,446 | (540,753) | (28,025) | ||
Beginning balance (in shares) at Mar. 31, 2021 | 283,130,238 | 283,130,000 | |||||
Beginning balance at Mar. 31, 2021 | $ 1,113,601 | $ 283 | 1,653,328 | (513,799) | (26,211) | ||
Increase (Decrease) in Partners' Capital [Roll Forward] | |||||||
Foreign currency translation | 1,428 | 1,428 | |||||
Restricted stock units vested (in shares) | 1,049,000 | ||||||
Restricted stock units vested | 0 | $ 1 | (1) | ||||
Restricted stock awards forfeited (in shares) | (19,000) | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 372,000 | ||||||
Issuance of common stock related to employee stock purchase plan | $ 13,914 | $ 1 | 13,913 | ||||
Exercise of stock options (in shares) | 1,170,000 | 1,170,000 | |||||
Exercise of stock options | $ 23,651 | $ 1 | 23,650 | ||||
Share-based compensation | 71,950 | 71,950 | |||||
Equity repurchases | (51) | (51) | |||||
Net income | $ 51,522 | 51,522 | |||||
Ending balance (in shares) at Dec. 31, 2021 | 285,701,744 | 285,702,000 | |||||
Ending balance at Dec. 31, 2021 | $ 1,276,015 | $ 286 | 1,762,789 | (462,277) | (24,783) | ||
Beginning balance (in shares) at Sep. 30, 2021 | 285,025,000 | ||||||
Beginning balance at Sep. 30, 2021 | 1,221,002 | $ 285 | 1,723,056 | (476,864) | (25,475) | ||
Increase (Decrease) in Partners' Capital [Roll Forward] | |||||||
Foreign currency translation | 692 | 692 | |||||
Restricted stock units vested (in shares) | 252,000 | ||||||
Issuance of common stock related to employee stock purchase plan (in shares) | 168,000 | ||||||
Issuance of common stock related to employee stock purchase plan | 7,321 | $ 1 | 7,320 | ||||
Exercise of stock options (in shares) | 257,000 | ||||||
Exercise of stock options | 5,311 | 5,311 | |||||
Share-based compensation | 27,123 | 27,123 | |||||
Equity repurchases | (21) | (21) | |||||
Net income | $ 14,587 | 14,587 | |||||
Ending balance (in shares) at Dec. 31, 2021 | 285,701,744 | 285,702,000 | |||||
Ending balance at Dec. 31, 2021 | $ 1,276,015 | $ 286 | $ 1,762,789 | $ (462,277) | $ (24,783) |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Cash flows from operating activities: | ||
Net income | $ 51,522 | $ 48,760 |
Adjustments to reconcile net income to cash provided by operations: | ||
Depreciation | 7,788 | 6,589 |
Amortization | 34,682 | 39,046 |
Share-based compensation | 71,950 | 43,091 |
Deferred income taxes | 34 | (3,014) |
Other | 2,872 | (1,240) |
Net change in operating assets and liabilities: | ||
Accounts receivable | (22,362) | (37,693) |
Deferred commissions | (19,581) | (6,380) |
Prepaid expenses and other assets | (17,508) | 25,920 |
Accounts payable and accrued expenses | 10,987 | 14,891 |
Operating leases, net | 683 | 599 |
Deferred revenue | 41,545 | 3,996 |
Net cash provided by operating activities | 162,612 | 134,565 |
Cash flows from investing activities: | ||
Purchase of property and equipment | (11,768) | (8,868) |
Capitalized software additions | 0 | (248) |
Acquisition of businesses, net of cash acquired | (13,195) | 0 |
Net cash used in investing activities | (24,963) | (9,116) |
Cash flows from financing activities: | ||
Repayment of term loans | (90,000) | (60,000) |
Proceeds from employee stock purchase plan | 13,913 | 9,195 |
Proceeds from exercise of stock options | 23,650 | 6,849 |
Equity repurchases | (51) | (36) |
Net cash used in financing activities | (52,488) | (43,992) |
Effect of exchange rates on cash and cash equivalents | (1,400) | 4,878 |
Net increase in cash and cash equivalents | 83,761 | 86,335 |
Cash and cash equivalents, beginning of period | 324,962 | 213,170 |
Cash and cash equivalents, end of period | 408,723 | 299,505 |
Supplemental cash flow data: | ||
Cash paid for interest | 6,549 | 9,914 |
Cash paid for (received from) tax, net | $ 12,902 | $ (14,472) |
Description of the Business
Description of the Business | 9 Months Ended |
Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of the Business | Description of the Business Business Dynatrace, Inc. (“Dynatrace”, or the “Company”) offers an observability platform, purpose-built for modern multicloud environments. The Company designed its all-in-one Dynatrace ® Software Intelligence Platform to address the growing complexity faced by technology and digital business teams as these enterprises further embrace the cloud to effect their digital transformation. The Company’s platform does so by utilizing artificial intelligence at its core and continuous automation to deliver precise answers about the performance and security of applications, the underlying infrastructure, and the experience of its customers’ users that enables organizations to innovate faster, operate more efficiently, and improve user experiences for consistently better business outcomes. Fiscal year The Company’s fiscal year ends on March 31. References to fiscal 2022, for example, refer to the fiscal year ended March 31, 2022. |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Basis of presentation and consolidation The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. All intercompany balances and transactions have been eliminated in the accompanying condensed consolidated financial statements. Unaudited interim consolidated financial information The accompanying interim condensed consolidated balance sheet as of December 31, 2021 and the interim condensed consolidated statements of operations, statements of comprehensive income, and statements of shareholders’ equity for the three and nine months ended December 31, 2021 and 2020, statements of cash flows for the nine months ended December 31, 2021 and 2020, and the related disclosures, are unaudited. In management’s opinion, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and includes all normal and recurring adjustments necessary for the fair presentation of the Company’s financial position as of December 31, 2021, its results of operations for the three and nine months ended December 31, 2021 and 2020, and its cash flows for the nine months ended December 31, 2021 and 2020 in accordance with U.S. GAAP. The results for the three and nine months ended December 31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year or any other interim period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021 (“Annual Report”). Use of estimates The preparation of unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Management periodically evaluates such estimates and assumptions for continued reasonableness. In particular, the Company makes estimates with respect to the stand-alone selling price for each distinct performance obligation in customer contracts with multiple performance obligations, the uncollectible accounts receivable, the fair value of tangible and intangible assets acquired, valuation of long-lived assets, the period of benefit for deferred commissions and material rights, share-based compensation expense, income taxes, and the determination of the incremental borrowing rate used for operating lease liabilities, among other things. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. Actual results could differ from those estimates. Significant accounting policies The Company’s significant accounting policies are discussed in Note 2, “Significant Accounting Policies” in the Company’s Annual Report. There have been no changes to the Company’s significant accounting policies described in the Company’s Annual Report that have had a material impact on its condensed consolidated financial statements and related notes. Recently adopted accounting pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. ASU 2019-12 is effective for annual periods, and interim periods within those years, beginning after December 15, 2020. The Company adopted the new standard on a prospective basis as of April 1, 2021. The adoption did not have a material impact on the condensed consolidated financial statements. Recently issued accounting pronouncements In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. ASU 2021-08 is effective for annual periods beginning after December 15, 2022, and interim periods within those years, with early adoption permitted. The Company plans to early adopt this standard in the fourth quarter of fiscal 2022 and does not expect the standard to have a material effect on its condensed consolidated financial statements. |
Revenue Recognition
Revenue Recognition | 9 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition Disaggregation of revenue The following table is a summary of the Company’s total revenues by geographic region (in thousands, except percentages): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Amount % Amount % Amount % Amount % North America $ 133,704 55 % $ 100,918 55 % $ 370,368 55 % $ 281,806 56 % Europe, Middle East and Africa 71,102 30 % 55,945 31 % 207,493 31 % 154,868 30 % Asia Pacific 24,927 10 % 20,643 11 % 71,002 10 % 56,854 11 % Latin America 11,033 5 % 5,405 3 % 27,997 4 % 13,477 3 % Total revenue $ 240,766 $ 182,911 $ 676,860 $ 507,005 For the three and nine months ended December 31, 2021 and 2020, the United States was the only country that represented more than 10% of the Company’s revenues in any period, constituting $124.3 million and 52% and $94.2 million and 51% of total revenue during the three months ended December 31, 2021 and 2020, respectively, and $343.9 million and 51% and $263.3 million and 52% of total revenue for the nine months ended December 31, 2021 and 2020, respectively. Deferred revenue Revenues recognized during the three months ended December 31, 2021 and 2020, which was included in the deferred revenue balances at the beginning of each respective period, was $110.6 million and $87.1 million, respectively. Revenues recognized during the nine months ended December 31, 2021 and 2020 which was included in the deferred revenue balances at the beginning of each respective period, was $447.2 million and $339.5 million, respectively. Remaining performance obligations As of December 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,402.0 million, which consists of both billed consideration in the amount of $594.0 million and unbilled consideration in the amount of $808.0 million that the Company expects to recognize as subscription and service revenue. The Company expects to recognize 57% of this amount as revenue over the next twelve months and the remainder thereafter. |
Goodwill and Other Intangible A
Goodwill and Other Intangible Assets, Net | 9 Months Ended |
Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets, Net | Goodwill and Other Intangible Assets, Net Changes in the carrying amount of goodwill on a consolidated basis for the nine months ended December 31, 2021 consists of the following (in thousands): December 31, 2021 Balance, beginning of period $ 1,271,195 Goodwill from acquisitions (1) 10,374 Foreign currency impact 195 Balance, end of period $ 1,281,764 _________________ (1) The initial allocation of the purchase price from acquisitions was based on preliminary valuations and assumptions and is subject to change. The Company expects to finalize the allocation of the purchase prices within the measurement period. Other intangible assets, net excluding goodwill consists of the following (in thousands): Weighted December 31, 2021 March 31, 2021 Capitalized software 107 $ 192,536 $ 189,398 Customer relationships 120 351,555 351,555 Trademarks and tradenames 120 55,003 55,003 Total intangible assets 599,094 595,956 Less: accumulated amortization (481,186) (446,472) Total other intangible assets, net $ 117,908 $ 149,484 |
Income Taxes
Income Taxes | 9 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company computes its interim provision for income taxes by applying the estimated annual effective tax rate to income from operations and adjusts the provision for discrete tax items occurring in the period. The Company’s effective tax rate for the three months ended December 31, 2021 was 16% compared to 21% for the three months ended December 31, 2020. The Company’s effective tax rate for the nine months ended December 31, 2021 was 5% compared to 22% for the nine months ended December 31, 2020. The decrease in the effective tax rate for both the three months ended December 31, 2021 and 2020 and nine months ended December 31, 2021 and 2020 is primarily due to additional share-based compensation tax windfall benefits and a $2.1 million one-time benefit related to anticipated tax refunds resulting from a favorable Polish research and development ruling received by the Company in August 2021. Based on the Company’s review of both positive and negative evidence regarding the realizability of deferred tax assets at December 31, 2021, a valuation allowance continues to be recorded against certain deferred tax assets based upon the conclusion that it was more likely than not that these assets would not be realized. The valuation allowance at December 31, 2021 relates primarily to accrued interest, capitalized development costs, and foreign tax credits. Given the Company’s current earnings and anticipated future earnings, it is reasonably possible that within the next twelve months sufficient positive evidence may become available to allow the Company to conclude that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets. However, the exact timing and amount of the valuation allowance release are subject to change based on the Company’s growth and profitability. |
Long-term Debt
Long-term Debt | 9 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Long-term Debt | Long-term Debt Long-term debt consists of the following (in thousands, except percentages): December 31, 2021 March 31, 2021 Amount Effective Rate Amount Effective Rate First Lien Term Loan $ 311,125 2.4 % $ 401,125 2.4 % Revolving credit facility — — Total principal 311,125 401,125 Unamortized discount and debt issuance costs (7,710) (9,212) Total debt 303,415 391,913 Less: Current portion of long-term debt — — Long-term debt $ 303,415 $ 391,913 First lien credit facilities The Company’s First Lien Credit Agreement, as amended, provides for a term loan facility, or the First Lien Term Loan, in an aggregate principal amount of $950.0 million and a senior secured revolving credit facility, or the Revolving Facility, in an aggregate amount of $60.0 million. The Revolving Facility includes a $25.0 million letter of credit sub-facility. The First Lien Term Loan and Revolving Facility mature on August 23, 2025 and August 23, 2023, respectively. There were $15.7 million and $15.6 million letters of credit issued as of December 31, 2021 and March 31, 2021, respectively. The Company had $44.3 million and $44.4 million of availability under the Revolving Facility as of December 31, 2021 and March 31, 2021, respectively. Borrowings under the First Lien Term Loan and the Revolving Facility currently bear interest, at the Company’s election, at either (i) the Alternative Base Rate, as defined per the credit agreement, plus 1.25% per annum, or (ii) LIBOR plus 2.25% per annum. The Company has satisfied all required principal payments under the First Lien Term Loan and the remainder is due at maturity. Interest payments are due quarterly, or more frequently, based on the terms of the credit agreement. The Company incurs fees with respect to the Revolving Facility, including (i) a commitment fee of 0.25% per annum of unused commitments under the Revolving Facility, (ii) facility fees equal to the applicable margin in effect for Eurodollar Rate Loans, as defined per the credit agreement, times the average daily stated amount of letters of credit, (iii) a fronting fee equal to either (a) 0.125% per annum on the stated amount of each letter of credit or (b) such other rate per annum as agreed to by the parties subject to the letters of credit, and (iv) customary administrative fees. All of the indebtedness under the First Lien Credit Agreement is and will be guaranteed by the Company’s existing and future material domestic subsidiaries and is and will be secured by substantially all of the assets of the Company and such guarantors. The First Lien Credit Agreement contains customary negative covenants. At December 31, 2021, the Company was in compliance with all applicable covenants. |
Leases
Leases | 9 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Leases | Leases The Company leases office space under non-cancelable operating leases which expire at various dates from fiscal 2022 to 2032. As of December 31, 2021, the weighted average remaining lease term was 6.2 years and the weighted average discount rate was 5.7%. The Company does not have any finance leases as of December 31, 2021. The Company has a sublease of a former office which expires in fiscal 2025. Sublease income from operating leases, which is recorded as a reduction of rental expense, was $0.8 million and $1.0 million for the three months ended December 31, 2021 and 2020, respectively, and $1.9 million and $3.3 million for the nine months ended December 31, 2021 and 2020, respectively. The following table presents information about leases on the condensed consolidated statements of operations (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2021 2020 2021 2020 Operating lease expense (1) $ 2,838 $ 2,640 $ 7,919 $ 8,022 Short-term lease expense $ 258 $ 174 $ 699 $ 524 Variable lease expense $ 202 $ 205 $ 574 $ 549 _________________ (1) Presented gross of sublease income. The following table presents supplemental cash flow information about the Company’s leases (in thousands): Nine Months Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of lease liabilities $ 9,912 $ 10,251 Operating lease assets obtained in exchange for new operating lease liabilities (1) $ 25,151 $ 2,600 _________________ (1) Includes the impact of new leases as well as remeasurements and modifications of existing leases. As of December 31, 2021, remaining maturities of lease liabilities were as follows (in thousands): Fiscal Years Ending March 31, Amount 2022 $ 3,535 2023 14,987 2024 14,303 2025 11,323 2026 8,349 Thereafter 22,083 Total operating lease payments (1) 74,580 Less: imputed interest (9,904) Total operating lease liabilities $ 64,676 _________________ (1) Presented gross of sublease income. As of December 31, 2021, the Company had commitments of $5.8 million for operating leases that have not yet commenced, and therefore are not included in the right-of-use assets or operating lease liabilities. These operating leases are expected to commence during the fiscal years ended March 31, 2022 and March 31, 2023, with lease terms ranging from 5 to 6 years. |
Leases | Leases The Company leases office space under non-cancelable operating leases which expire at various dates from fiscal 2022 to 2032. As of December 31, 2021, the weighted average remaining lease term was 6.2 years and the weighted average discount rate was 5.7%. The Company does not have any finance leases as of December 31, 2021. The Company has a sublease of a former office which expires in fiscal 2025. Sublease income from operating leases, which is recorded as a reduction of rental expense, was $0.8 million and $1.0 million for the three months ended December 31, 2021 and 2020, respectively, and $1.9 million and $3.3 million for the nine months ended December 31, 2021 and 2020, respectively. The following table presents information about leases on the condensed consolidated statements of operations (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2021 2020 2021 2020 Operating lease expense (1) $ 2,838 $ 2,640 $ 7,919 $ 8,022 Short-term lease expense $ 258 $ 174 $ 699 $ 524 Variable lease expense $ 202 $ 205 $ 574 $ 549 _________________ (1) Presented gross of sublease income. The following table presents supplemental cash flow information about the Company’s leases (in thousands): Nine Months Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of lease liabilities $ 9,912 $ 10,251 Operating lease assets obtained in exchange for new operating lease liabilities (1) $ 25,151 $ 2,600 _________________ (1) Includes the impact of new leases as well as remeasurements and modifications of existing leases. As of December 31, 2021, remaining maturities of lease liabilities were as follows (in thousands): Fiscal Years Ending March 31, Amount 2022 $ 3,535 2023 14,987 2024 14,303 2025 11,323 2026 8,349 Thereafter 22,083 Total operating lease payments (1) 74,580 Less: imputed interest (9,904) Total operating lease liabilities $ 64,676 _________________ (1) Presented gross of sublease income. As of December 31, 2021, the Company had commitments of $5.8 million for operating leases that have not yet commenced, and therefore are not included in the right-of-use assets or operating lease liabilities. These operating leases are expected to commence during the fiscal years ended March 31, 2022 and March 31, 2023, with lease terms ranging from 5 to 6 years. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Legal matters From time to time, the Company may be a party to lawsuits and legal proceedings arising in the ordinary course of business. In the opinion of the Company’s management, these matters, individually and in the aggregate, will not have a material adverse effect on the financial condition and results of the future operations of the Company. |
Share-based Compensation
Share-based Compensation | 9 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Share-based Compensation | Share-based Compensation Amended and Restated 2019 Equity Incentive Plan In July 2019, the Company’s board of directors (the “Board”), upon the recommendation of the compensation committee of the board of directors, adopted the 2019 Equity Incentive Plan, as amended and restated (the “2019 Plan”) which was subsequently approved by the Company’s shareholders and was later amended and restated by the Board in January 2021. The Company initially reserved 52,000,000 shares of common stock, or the Initial Limit, for the issuance of awards under the 2019 Plan. The 2019 Plan provides that the number of shares reserved and available for issuance under the plan will automatically increase each April 1, beginning on April 1, 2020, by 4% of the outstanding number of shares of the Company’s common stock on the immediately preceding March 31 or such lesser number determined by the compensation committee. This number is subject to adjustment in the event of a stock split, stock dividend or other change in the Company’s capitalization. As of December 31, 2021, 37,834,512 shares of common stock were available for future issuance under the 2019 Plan. Stock options The following table summarizes activity for stock options during the period ended December 31, 2021: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) (per share) (years) (in thousands) Balance, March 31, 2021 8,393 $ 21.31 8.6 $ 226,438 Granted 115 52.86 Exercised (1,170) 20.22 Forfeited (244) 25.05 Balance, December 31, 2021 7,094 $ 21.87 7.8 $ 272,958 Options vested and expected to vest at December 31, 2021 7,094 $ 21.87 7.8 $ 272,958 Options vested and exercisable at December 31, 2021 2,674 $ 19.68 7.7 $ 108,749 As of December 31, 2021, the total unrecognized compensation expense related to non-vested stock options is $37.0 million and is expected to be recognized over a weighted average period of 1.9 years. The Company recognized $5.6 million and $4.5 million of share-based compensation expense related to stock options for the three months ended December 31, 2021 and 2020, respectively, and $14.9 million and $12.3 million of share-based compensation expense related to stock options for the nine months ended December 31, 2021 and 2020, respectively. Restricted shares and units The following table provides a summary of the changes in the number of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) for the period ended December 31, 2021: Number of Weighted Average Grant Date Fair Value Number of RSUs Weighted Average (in thousands) (per share) (in thousands) (per share) Balance, March 31, 2021 728 $ 16.00 3,041 $ 24.44 Granted — — 3,269 51.29 Vested (440) 16.00 (1,049) 24.24 Forfeited (19) 16.00 (232) 33.51 Balance, December 31, 2021 269 $ 16.00 5,029 $ 41.52 RSUs outstanding as of December 31, 2021 were comprised of 4.0 million RSUs with only service conditions and 1.0 million RSUs with both service and performance conditions (“PSUs”). During the three and nine months ended December 31, 2021, the Company granted PSUs to certain key employees that generally vest in three equal installments, with one-third of the PSUs eligible to vest on each of the first three During the three and nine months ended December 31, 2021, the Company granted PSUs to certain key employees that vest 25% one three Compensation expense for the PSUs are measured using the fair value at the date of grant and recorded over their respective vesting periods under the graded-vesting attribution method and may be adjusted over the vesting period based on interim estimates of performance against the pre-set objectives. As of December 31, 2021, the total unrecognized compensation expense related to unvested restricted stock awards is $3.2 million and is expected to be recognized over a weighted average period of 0.8 years. As of December 31, 2021, the total unrecognized compensation expense related to unvested restricted stock units is $180.6 million and is expected to be recognized over a weighted average period of 2.5 years. The Company recognized $20.3 million and $9.6 million of share-based compensation expense related to restricted shares and units for the three months ended December 31, 2021 and 2020, respectively, and $53.4 million and $28.3 million of share-based compensation expense related to restricted shares and units for the nine months ended December 31, 2021 and 2020, respectively. Employee Stock Purchase Plan In July 2019, the board of directors adopted, and the Company’s shareholders approved, the 2019 Employee Stock Purchase Plan (“ESPP”). The Company expects to offer, sell and issue shares of common stock under this ESPP from time to time based on various factors and conditions, although the Company is under no obligation to sell any shares under this ESPP. The ESPP provides for six-month offering periods beginning May 15 and November 15 of each year, and each offering period will consist of six As of December 31, 2021, there was approximately $2.3 million of unrecognized share-based compensation related to the ESPP that is expected to be recognized over the remaining term of the current offering period. The Company recognized $1.2 million and $1.5 million of share-based compensation expense related to the ESPP for the three months ended December 31, 2021 and 2020, respectively, and $3.6 million and $2.5 million of share-based compensation expense related to the ESPP for the nine months ended December 31, 2021 and 2020, respectively. Share-based compensation The following table summarizes the components of total share-based compensation expense included in the condensed consolidated financial statements for each period presented (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Cost of revenue $ 3,405 $ 2,066 $ 9,542 $ 5,430 Research and development 5,908 3,259 15,331 8,666 Sales and marketing 9,267 6,480 26,487 18,007 General and administrative 8,543 3,783 20,590 10,988 Total share-based compensation $ 27,123 $ 15,588 $ 71,950 $ 43,091 |
Net Income Per Share
Net Income Per Share | 9 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | Net Income Per ShareBasic net income per share is calculated by dividing the net income for the period by the weighted-average number of common shares outstanding during the period, without consideration of potentially dilutive securities. Diluted net income per share includes the dilutive effect of common share equivalents and is calculated using the weighted-average number of common shares and the common share equivalents outstanding during the reporting period. An anti-dilutive impact is an increase in net income per share or a reduction in net loss per share resulting from the conversion, exercise, or contingent issuance of certain securities. The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Numerator: Net income $ 14,587 $ 18,416 $ 51,522 $ 48,760 Denominator: Weighted average shares outstanding, basic 284,722 281,010 283,773 280,057 Dilutive effect of stock-based awards 7,123 5,417 7,122 5,827 Weighted average shares outstanding, diluted 291,845 286,427 290,895 285,884 Net income per share, basic $ 0.05 $ 0.07 $ 0.18 $ 0.17 Net income per share, diluted $ 0.05 $ 0.06 $ 0.18 $ 0.17 The effect of certain common share equivalents were excluded from the computation of weighted average diluted shares outstanding for the three and nine months ended December 31, 2021 and 2020 as inclusion would have resulted in anti-dilution. A summary of these weighted-average anti-dilutive common share equivalents is provided in the table below (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Stock options 147 2,185 167 1,777 Unvested RSAs and RSUs 49 6 67 31 Shares committed under ESPP — 2 — 2 |
Geographic Information
Geographic Information | 9 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Geographic Information | Geographic Information Revenue Revenues by geography are based on legal jurisdiction. Refer to Note 3, “Revenue Recognition” for a disaggregation of revenue by geographic region. Property and equipment, net The following tables present property and equipment by geographic region for the periods presented (in thousands): December 31, 2021 March 31, 2021 North America $ 14,636 $ 12,129 Europe, Middle East and Africa 25,813 23,124 Asia Pacific 1,397 1,619 Latin America 138 44 Total property and equipment, net $ 41,984 $ 36,916 |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 9 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Fiscal year | The Company’s fiscal year ends on March 31. References to fiscal 2022, for example, refer to the fiscal year ended March 31, 2022. |
Consolidation | The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. All intercompany balances and transactions have been eliminated in the accompanying condensed consolidated financial statements. |
Basis of presentation | Unaudited interim consolidated financial information The accompanying interim condensed consolidated balance sheet as of December 31, 2021 and the interim condensed consolidated statements of operations, statements of comprehensive income, and statements of shareholders’ equity for the three and nine months ended December 31, 2021 and 2020, statements of cash flows for the nine months ended December 31, 2021 and 2020, and the related disclosures, are unaudited. In management’s opinion, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and includes all normal and recurring adjustments necessary for the fair presentation of the Company’s financial position as of December 31, 2021, its results of operations for the three and nine months ended December 31, 2021 and 2020, and its cash flows for the nine months ended December 31, 2021 and 2020 in accordance with U.S. GAAP. The results for the three and nine months ended December 31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year or any other interim period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021 (“Annual Report”). |
Use of estimates | Use of estimates The preparation of unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Management periodically evaluates such estimates and assumptions for continued reasonableness. In particular, the Company makes estimates with respect to the stand-alone selling price for each distinct performance obligation in customer contracts with multiple performance obligations, the uncollectible accounts receivable, the fair value of tangible and intangible assets acquired, valuation of long-lived assets, the period of benefit for deferred commissions and material rights, share-based compensation expense, income taxes, and the determination of the incremental borrowing rate used for operating lease liabilities, among other things. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. Actual results could differ from those estimates. |
Recently adopted accounting pronouncements and recently issues accounting pronouncements | Recently adopted accounting pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. ASU 2019-12 is effective for annual periods, and interim periods within those years, beginning after December 15, 2020. The Company adopted the new standard on a prospective basis as of April 1, 2021. The adoption did not have a material impact on the condensed consolidated financial statements. Recently issued accounting pronouncements In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. ASU 2021-08 is effective for annual periods beginning after December 15, 2022, and interim periods within those years, with early adoption permitted. The Company plans to early adopt this standard in the fourth quarter of fiscal 2022 and does not expect the standard to have a material effect on its condensed consolidated financial statements. |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | The following table is a summary of the Company’s total revenues by geographic region (in thousands, except percentages): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Amount % Amount % Amount % Amount % North America $ 133,704 55 % $ 100,918 55 % $ 370,368 55 % $ 281,806 56 % Europe, Middle East and Africa 71,102 30 % 55,945 31 % 207,493 31 % 154,868 30 % Asia Pacific 24,927 10 % 20,643 11 % 71,002 10 % 56,854 11 % Latin America 11,033 5 % 5,405 3 % 27,997 4 % 13,477 3 % Total revenue $ 240,766 $ 182,911 $ 676,860 $ 507,005 |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets, Net (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | Changes in the carrying amount of goodwill on a consolidated basis for the nine months ended December 31, 2021 consists of the following (in thousands): December 31, 2021 Balance, beginning of period $ 1,271,195 Goodwill from acquisitions (1) 10,374 Foreign currency impact 195 Balance, end of period $ 1,281,764 _________________ (1) The initial allocation of the purchase price from acquisitions was based on preliminary valuations and assumptions and is subject to change. The Company expects to finalize the allocation of the purchase prices within the measurement period. |
Schedule of Intangible Assets | Other intangible assets, net excluding goodwill consists of the following (in thousands): Weighted December 31, 2021 March 31, 2021 Capitalized software 107 $ 192,536 $ 189,398 Customer relationships 120 351,555 351,555 Trademarks and tradenames 120 55,003 55,003 Total intangible assets 599,094 595,956 Less: accumulated amortization (481,186) (446,472) Total other intangible assets, net $ 117,908 $ 149,484 |
Long-term Debt - Schedule of Lo
Long-term Debt - Schedule of Long-Term Debt (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt Instruments | Long-term debt consists of the following (in thousands, except percentages): December 31, 2021 March 31, 2021 Amount Effective Rate Amount Effective Rate First Lien Term Loan $ 311,125 2.4 % $ 401,125 2.4 % Revolving credit facility — — Total principal 311,125 401,125 Unamortized discount and debt issuance costs (7,710) (9,212) Total debt 303,415 391,913 Less: Current portion of long-term debt — — Long-term debt $ 303,415 $ 391,913 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Schedule of Lease Expense and Supplemental Cash Flow Information | The following table presents information about leases on the condensed consolidated statements of operations (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2021 2020 2021 2020 Operating lease expense (1) $ 2,838 $ 2,640 $ 7,919 $ 8,022 Short-term lease expense $ 258 $ 174 $ 699 $ 524 Variable lease expense $ 202 $ 205 $ 574 $ 549 _________________ (1) Presented gross of sublease income. The following table presents supplemental cash flow information about the Company’s leases (in thousands): Nine Months Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of lease liabilities $ 9,912 $ 10,251 Operating lease assets obtained in exchange for new operating lease liabilities (1) $ 25,151 $ 2,600 _________________ (1) Includes the impact of new leases as well as remeasurements and modifications of existing leases. |
Schedule of Maturities of Lease Liabilities | As of December 31, 2021, remaining maturities of lease liabilities were as follows (in thousands): Fiscal Years Ending March 31, Amount 2022 $ 3,535 2023 14,987 2024 14,303 2025 11,323 2026 8,349 Thereafter 22,083 Total operating lease payments (1) 74,580 Less: imputed interest (9,904) Total operating lease liabilities $ 64,676 _________________ (1) Presented gross of sublease income. |
Share-based Compensation (Table
Share-based Compensation (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Summary of Activity for Stock Options | The following table summarizes activity for stock options during the period ended December 31, 2021: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) (per share) (years) (in thousands) Balance, March 31, 2021 8,393 $ 21.31 8.6 $ 226,438 Granted 115 52.86 Exercised (1,170) 20.22 Forfeited (244) 25.05 Balance, December 31, 2021 7,094 $ 21.87 7.8 $ 272,958 Options vested and expected to vest at December 31, 2021 7,094 $ 21.87 7.8 $ 272,958 Options vested and exercisable at December 31, 2021 2,674 $ 19.68 7.7 $ 108,749 |
Summary of Activity for Restricted Shares | The following table provides a summary of the changes in the number of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) for the period ended December 31, 2021: Number of Weighted Average Grant Date Fair Value Number of RSUs Weighted Average (in thousands) (per share) (in thousands) (per share) Balance, March 31, 2021 728 $ 16.00 3,041 $ 24.44 Granted — — 3,269 51.29 Vested (440) 16.00 (1,049) 24.24 Forfeited (19) 16.00 (232) 33.51 Balance, December 31, 2021 269 $ 16.00 5,029 $ 41.52 |
Schedule of Share-based Compensation Expense | The following table summarizes the components of total share-based compensation expense included in the condensed consolidated financial statements for each period presented (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Cost of revenue $ 3,405 $ 2,066 $ 9,542 $ 5,430 Research and development 5,908 3,259 15,331 8,666 Sales and marketing 9,267 6,480 26,487 18,007 General and administrative 8,543 3,783 20,590 10,988 Total share-based compensation $ 27,123 $ 15,588 $ 71,950 $ 43,091 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Summary of Basic and Diluted Net Loss Per Share | The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Numerator: Net income $ 14,587 $ 18,416 $ 51,522 $ 48,760 Denominator: Weighted average shares outstanding, basic 284,722 281,010 283,773 280,057 Dilutive effect of stock-based awards 7,123 5,417 7,122 5,827 Weighted average shares outstanding, diluted 291,845 286,427 290,895 285,884 Net income per share, basic $ 0.05 $ 0.07 $ 0.18 $ 0.17 Net income per share, diluted $ 0.05 $ 0.06 $ 0.18 $ 0.17 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | A summary of these weighted-average anti-dilutive common share equivalents is provided in the table below (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2021 2020 2021 2020 Stock options 147 2,185 167 1,777 Unvested RSAs and RSUs 49 6 67 31 Shares committed under ESPP — 2 — 2 |
Geographic Information (Tables)
Geographic Information (Tables) | 9 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Summary of Property and Equipment by Geographical Region | The following tables present property and equipment by geographic region for the periods presented (in thousands): December 31, 2021 March 31, 2021 North America $ 14,636 $ 12,129 Europe, Middle East and Africa 25,813 23,124 Asia Pacific 1,397 1,619 Latin America 138 44 Total property and equipment, net $ 41,984 $ 36,916 |
Revenue Recognition - Schedule
Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||||
Amount | $ 240,766 | $ 182,911 | $ 676,860 | $ 507,005 |
North America | ||||
Disaggregation of Revenue [Line Items] | ||||
Amount | $ 133,704 | $ 100,918 | $ 370,368 | $ 281,806 |
North America | Revenue Benchmark | Geographic Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
% | 55.00% | 55.00% | 55.00% | 56.00% |
Europe, Middle East and Africa | ||||
Disaggregation of Revenue [Line Items] | ||||
Amount | $ 71,102 | $ 55,945 | $ 207,493 | $ 154,868 |
Europe, Middle East and Africa | Revenue Benchmark | Geographic Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
% | 30.00% | 31.00% | 31.00% | 30.00% |
Asia Pacific | ||||
Disaggregation of Revenue [Line Items] | ||||
Amount | $ 24,927 | $ 20,643 | $ 71,002 | $ 56,854 |
Asia Pacific | Revenue Benchmark | Geographic Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
% | 10.00% | 11.00% | 10.00% | 11.00% |
Latin America | ||||
Disaggregation of Revenue [Line Items] | ||||
Amount | $ 11,033 | $ 5,405 | $ 27,997 | $ 13,477 |
Latin America | Revenue Benchmark | Geographic Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
% | 5.00% | 3.00% | 4.00% | 3.00% |
Revenue Recognition - Disaggreg
Revenue Recognition - Disaggregation of Revenue and Deferred Revenue (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 240,766 | $ 182,911 | $ 676,860 | $ 507,005 |
Revenue recognized | 110,600 | 87,100 | 447,200 | 339,500 |
Revenue Benchmark | Geographic Concentration Risk | UNITED STATES | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 124,300 | $ 94,200 | $ 343,900 | $ 263,300 |
Concentration risk percentage | 52.00% | 51.00% | 51.00% | 52.00% |
Revenue Recognition - Remaining
Revenue Recognition - Remaining Performance Obligations (Narrative) (Details) $ in Millions | Dec. 31, 2021USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, amount | $ 1,402 |
Billed consideration | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, amount | 594 |
Unbilled consideration | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, amount | $ 808 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, percentage | 57.00% |
Remaining performance obligation, expected timing of satisfaction, period | 12 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation, percentage | 43.00% |
Remaining performance obligation, expected timing of satisfaction, period |
Goodwill and Other Intangible_3
Goodwill and Other Intangible Assets, Net - Schedule of Goodwill (Details) $ in Thousands | 9 Months Ended |
Dec. 31, 2021USD ($) | |
Goodwill [Roll Forward] | |
Balance, beginning of period | $ 1,271,195 |
Goodwill from acquisitions | 10,374 |
Foreign currency impact | 195 |
Balance, end of period | $ 1,281,764 |
Goodwill and Other Intangible_4
Goodwill and Other Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Dec. 31, 2021 | Mar. 31, 2021 | |
Finite-Lived Intangible Assets [Line Items] | ||
Total intangible assets | $ 599,094 | $ 595,956 |
Less: accumulated amortization | (481,186) | (446,472) |
Total other intangible assets, net | $ 117,908 | 149,484 |
Capitalized software | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted Average Useful Life (in months) | 107 years | |
Total intangible assets | $ 192,536 | 189,398 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted Average Useful Life (in months) | 120 months | |
Total intangible assets | $ 351,555 | 351,555 |
Trademarks and tradenames | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted Average Useful Life (in months) | 120 months | |
Total intangible assets | $ 55,003 | $ 55,003 |
Goodwill and Other Intangible_5
Goodwill and Other Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of other intangibles | $ 11,600 | $ 13,000 | $ 34,682 | $ 39,046 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | ||||
Effective tax rate | 16.00% | 21.00% | 5.00% | 22.00% |
Anticipated tax refunds | $ 2.1 | $ 2.1 | $ 2.1 | $ 2.1 |
Long-term Debt - Schedule of _2
Long-term Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2021 | Mar. 31, 2021 |
Debt Instrument [Line Items] | ||
Total principal | $ 311,125 | $ 401,125 |
Unamortized discount and debt issuance costs | (7,710) | (9,212) |
Total debt | 303,415 | 391,913 |
Less: Current portion of long-term debt | 0 | 0 |
Long-term debt | 303,415 | 391,913 |
First Lien Term Loan | Secured Debt | ||
Debt Instrument [Line Items] | ||
Total principal | $ 311,125 | $ 401,125 |
Effective Rate | 2.40% | 2.40% |
Revolving credit facility | Line of Credit | Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Total principal | $ 0 | $ 0 |
Long-term Debt - Narrative (Det
Long-term Debt - Narrative (Details) - USD ($) | 9 Months Ended | |
Dec. 31, 2021 | Mar. 31, 2021 | |
First Lien Term Loan | Secured Debt | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 950,000,000 | |
First Lien Term Loan | Secured Debt | Alternative Base Rate | ||
Debt Instrument [Line Items] | ||
Basis spread on variable interest rate | 1.25% | |
First Lien Term Loan | Secured Debt | London Interbank Offered Rate (LIBOR) | ||
Debt Instrument [Line Items] | ||
Basis spread on variable interest rate | 2.25% | |
Revolving credit facility | Line of Credit | Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Maximum borrowing capacity | $ 60,000,000 | |
Available borrowing capacity | $ 44,300,000 | $ 44,400,000 |
Commitment fee percentage | 0.25% | |
Fronting fee percentage | 0.125% | |
Revolving credit facility | Line of Credit | Letter of Credit | ||
Debt Instrument [Line Items] | ||
Maximum borrowing capacity | $ 25,000,000 | |
Letters of credit issued | $ 15,700,000 | $ 15,600,000 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Lessee, Lease, Description [Line Items] | ||||
Weighted average remaining lease term | 6 years 2 months 12 days | 6 years 2 months 12 days | ||
Weighted average discount rate | 5.70% | 5.70% | ||
Sublease Income | $ 0.8 | $ 1 | $ 1.9 | $ 3.3 |
Operating lease that has not yet commenced | $ 5.8 | $ 5.8 | ||
Minimum | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease that has not yet commenced, term | 5 years | 5 years | ||
Maximum | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease that has not yet commenced, term | 6 years | 6 years |
Leases - Schedule of Lease Expe
Leases - Schedule of Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | ||||
Operating lease expense | $ 2,838 | $ 2,640 | $ 7,919 | $ 8,022 |
Short-term lease expense | 258 | 174 | 699 | 524 |
Variable lease expense | $ 202 | $ 205 | $ 574 | $ 549 |
Leases - Schedule of Supplement
Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | ||
Cash paid for amounts included in the measurement of lease liabilities | $ 9,912 | $ 10,251 |
Operating lease assets obtained in exchange for new operating lease liabilities | $ 25,151 | $ 2,600 |
Leases - Schedule of Maturities
Leases - Schedule of Maturities of Lease Liabilities (Details) $ in Thousands | Dec. 31, 2021USD ($) |
Leases [Abstract] | |
2022 | $ 3,535 |
2023 | 14,987 |
2024 | 14,303 |
2025 | 11,323 |
2026 | 8,349 |
Thereafter | 22,083 |
Total operating lease payments | 74,580 |
Less: imputed interest | (9,904) |
Total operating lease liabilities | $ 64,676 |
Share-based Compensation - Narr
Share-based Compensation - Narrative (Details) $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||
Jul. 31, 2019shares | Dec. 31, 2021USD ($)installmentshares | Dec. 31, 2020USD ($) | Dec. 31, 2021USD ($)installmentshares | Dec. 31, 2020USD ($) | Mar. 31, 2021shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Total unrecognized compensation cost | $ 37,000 | $ 37,000 | ||||
Stock compensation expense | 27,123 | $ 15,588 | $ 71,950 | $ 43,091 | ||
Stock options | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Weighted average period of recognition | 1 year 10 months 24 days | |||||
Stock compensation expense | 5,600 | 4,500 | $ 14,900 | 12,300 | ||
Unvested RSAs and RSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Stock compensation expense | $ 20,300 | 9,600 | $ 53,400 | 28,300 | ||
Restricted Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Weighted average period of recognition | 9 months 18 days | |||||
Outstanding shares (in shares) | shares | 269,000 | 269,000 | 728,000 | |||
Total unrecognized compensation cost | $ 3,200 | $ 3,200 | ||||
Restricted Stock Units (RSUs) | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Weighted average period of recognition | 2 years 6 months | |||||
Outstanding shares (in shares) | shares | 5,029,000 | 5,029,000 | 3,041,000 | |||
Total unrecognized compensation cost | $ 180,600 | $ 180,600 | ||||
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche One | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Outstanding shares (in shares) | shares | 4,000,000 | 4,000,000 | ||||
Performance-Based Restricted Stock Units, Incentive PSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Number of equal installments | installment | 3 | 3 | ||||
Award vesting period | 3 years | 3 years | ||||
Minimum performance target percentage | 0.95 | |||||
Maximum percentage of shares issued based on performance target award | 1.50 | |||||
Performance-Based Restricted Stock Units, Incentive PSUs | Share-based Payment Arrangement, Tranche One | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting percentage | 33.30% | |||||
Performance-Based Restricted Stock Units, Incentive PSUs | Share-based Payment Arrangement, Tranche Two | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting percentage | 33.30% | |||||
Performance-Based Restricted Stock Units, Incentive PSUs | Share-based Payment Arrangement, Tranche Three | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting percentage | 33.30% | |||||
Performance-Based Restricted Stock Units, Annual PSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Maximum percentage of shares issued based on performance target award | 1.50 | |||||
Performance-Based Restricted Stock Units, Annual PSUs | Share-based Payment Arrangement, Tranche One | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting percentage | 25.00% | |||||
Award vesting period | 1 year | |||||
Performance-Based Restricted Stock Units, Annual PSUs | Share-based Payment Arrangement, Tranche Two | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting percentage | 75.00% | |||||
Number of equal installments | installment | 12 | |||||
Award vesting period | 3 years | |||||
Employee Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
ESPP offering period | 6 months | |||||
ESPP purchase period | 6 months | |||||
Employee Stock | Common Class A | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
ESPP, maximum percentage of the common stock available for purchase | 85.00% | |||||
Equity Incentive Plan 2019 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Units authorized for issuance (in shares) | shares | 52,000,000 | 37,834,512 | 37,834,512 | |||
Annual increase in shares reserved for future issuance based off of shares outstanding | 4.00% | |||||
2019 Employee Stock Purchase Plan | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Stock compensation expense | $ 1,200 | $ 1,500 | $ 3,600 | $ 2,500 | ||
Total unrecognized compensation cost | $ 2,300 | $ 2,300 | ||||
2019 Employee Stock Purchase Plan | Common Class A | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Units authorized for issuance (in shares) | shares | 11,187,354 | 11,187,354 | ||||
Issuance of common stock related to employee stock purchase plan (in shares) | shares | 371,740 |
Share-based Compensation - Sche
Share-based Compensation - Schedule of Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2021 | Mar. 31, 2021 | |
Number of Options | |||
Beginning balance (in shares) | 8,393 | 8,393 | |
Granted (in shares) | 115 | ||
Exercised (in shares) | (1,170) | ||
Forfeited (in shares) | (244) | ||
Ending balance (in shares) | 7,094 | ||
Options vested and expected to vest (in shares) | 7,094 | ||
Options vested and exercisable (in shares) | 2,674 | ||
Weighted Average Exercise Price | |||
Beginning balance (in dollars per share) | $ 21.31 | $ 21.31 | |
Granted (in dollars per share) | 52.86 | ||
Exercised (in dollars per share) | 20.22 | ||
Forfeited (in dollars per share) | 25.05 | ||
Ending valance (in dollars per share) | 21.87 | ||
Weighted average exercise price, options vested and expected to vest (in dollars per share) | 21.87 | ||
Weighted average exercise price, options vested and exercisable (in dollars per share) | $ 19.68 | ||
Weighted average remaining contractual term | 8 years 7 months 6 days | 7 years 9 months 18 days | |
Weighted average remaining contractual term, options vested and expected to vest | 7 years 9 months 18 days | ||
Weighted average remaining contractual term, options vested and exercisable | 7 years 8 months 12 days | ||
Aggregate intrinsic value | $ 272,958 | $ 226,438 | |
Aggregate intrinsic value, options vested and expected to vest | 272,958 | ||
Aggregate intrinsic value, options vested and exercisable | $ 108,749 | ||
Restricted Stock | |||
Number of Restricted Shares | |||
Beginning balance (in shares) | 728 | 728 | |
Granted (in shares) | 0 | ||
Vested (in shares) | (440) | ||
Forfeited (in shares) | (19) | ||
Ending balance (in shares) | 269 | ||
Weighted Average Grant Date Fair Value | |||
Beginning balance (in dollars per share) | $ 16 | $ 16 | |
Granted (in dollars per share) | 0 | ||
Vested (in dollars per share) | 16 | ||
Forfeited (in dollars per share) | 16 | ||
Ending balance (in dollars per share) | $ 16 | ||
Restricted Stock Units (RSUs) | |||
Number of Restricted Shares | |||
Beginning balance (in shares) | 3,041 | 3,041 | |
Granted (in shares) | 3,269 | ||
Vested (in shares) | (1,049) | ||
Forfeited (in shares) | (232) | ||
Ending balance (in shares) | 5,029 | ||
Weighted Average Grant Date Fair Value | |||
Beginning balance (in dollars per share) | $ 24.44 | $ 24.44 | |
Granted (in dollars per share) | 51.29 | ||
Vested (in dollars per share) | 24.24 | ||
Forfeited (in dollars per share) | 33.51 | ||
Ending balance (in dollars per share) | $ 41.52 | ||
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Two | |||
Number of Restricted Shares | |||
Granted (in shares) | 1,000 |
Share-based Compensation - Sc_2
Share-based Compensation - Schedule of Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total share-based compensation expense | $ 27,123 | $ 15,588 | $ 71,950 | $ 43,091 |
Cost of revenue | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total share-based compensation expense | 3,405 | 2,066 | 9,542 | 5,430 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total share-based compensation expense | 5,908 | 3,259 | 15,331 | 8,666 |
Sales and marketing | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total share-based compensation expense | 9,267 | 6,480 | 26,487 | 18,007 |
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total share-based compensation expense | $ 8,543 | $ 3,783 | $ 20,590 | $ 10,988 |
Net Income Per Share - Summary
Net Income Per Share - Summary of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Numerator: | ||||
Net income | $ 14,587 | $ 18,416 | $ 51,522 | $ 48,760 |
Denominator: | ||||
Weighted average shares outstanding, basic (in shares) | 284,722 | 281,010 | 283,773 | 280,057 |
Dilutive effect of stock-based awards (in shares) | 7,123 | 5,417 | 7,122 | 5,827 |
Weighted average shares outstanding, diluted (in shares) | 291,845 | 286,427 | 290,895 | 285,884 |
Net income per share, basic (in dollars per share) | $ 0.05 | $ 0.07 | $ 0.18 | $ 0.17 |
Net income per share, diluted (in dollars per share) | $ 0.05 | $ 0.06 | $ 0.18 | $ 0.17 |
Net Income Per Share - Antidilu
Net Income Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Stock options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive common share equivalents (in shares) | 147 | 2,185 | 167 | 1,777 |
Unvested RSAs and RSUs | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive common share equivalents (in shares) | 49 | 6 | 67 | 31 |
Shares committed under ESPP | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive common share equivalents (in shares) | 0 | 2 | 0 | 2 |
Geographic Information - Summar
Geographic Information - Summary of Property and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2021 | Mar. 31, 2021 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | $ 41,984 | $ 36,916 |
North America | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | 14,636 | 12,129 |
Europe, Middle East and Africa | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | 25,813 | 23,124 |
Asia Pacific | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | 1,397 | 1,619 |
Latin America | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total property and equipment, net | $ 138 | $ 44 |